Industry Perception - Crypto community considers fundamental concepts like revenue and privacy as mere "metas" [1] - The term "meta" is used even for basic necessities like drinking water (H2O) [1]

RT Ponyo (@13300RPM)Arete Capital (@Crypto_McKenna) just released their 2026 $HYPE valuation outlook:1. Revenue- Q3’25 annualized: $1.13B- Growth drivers: HyperCore (+$415M), Builder Codes (+$154M), Aligned Stablecoins (+$88M), HIP-3 markets (+$80M)-> EOY ’26 annualized revenue: $1.87B (+65%)2. Supply dynamics- HIP-3 operators: 4–12 exchanges × 500K HYPE → 2–6M HYPE staked- Aligned stablecoins: 1–3 issuers × 1M HYPE → 1–3M HYPE staked- Assistance Fund: 100% of annual revenue used for buybacks (~41.6M HYPE)- ...

City just reporting earnings. Leslie Picker joins us right now with more on that. Hi Leslie.Hey Becky. Yeah, City Group beating on the top line with all five divisions posting a record third quarter. Revenue overall up 9% to 22.1% billion.As for the individual units, banking, which houses investment banking and corporate banking, the biggest grower in the quarter with revenue up 34%. Markets comprising sales, trading, and financing was the highest earner generating 5.6% 6 billion in Q3. The other three divi ...

Core Insights - Abbott Laboratories is expected to report third-quarter earnings on October 15, 2025, with an anticipated EPS of $1.30, reflecting a 7.4% increase year-over-year, and projected revenue of $11.4 billion, up from $10.63 billion a year ago [1][6] Financial Performance - The anticipated EPS of $1.30 represents an 8.3% year-over-year growth, indicating strong performance despite a recent stock decline of 0.6%, closing at $132.57 [2] - Abbott's financial metrics include a price-to-earnings (P/E) ratio of approximately 16.36 and a price-to-sales ratio of about 5.30, suggesting a favorable market valuation [4] - The company's debt-to-equity ratio stands at 0.27, indicating a relatively low level of debt, while a current ratio of 1.82 reflects strong liquidity to cover short-term liabilities [4] Strategic Focus - Abbott's strategic emphasis on expanding its diabetes care solutions is identified as a key driver for future growth, transitioning from devices to comprehensive, data-driven care solutions [3][6] - This strategic move is expected to enhance Abbott's competitive edge and contribute to its long-term success in the healthcare industry [3] Analyst Insights - The consensus earnings estimate for Abbott has been slightly adjusted downward by 0.1% over the past month, reflecting analysts' reassessment of initial projections [5] - This adjustment could influence investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock price performance [5]

Core Insights - The article discusses the importance of enabling Javascript and cookies in browsers to ensure proper functionality and access to content [1] Group 1 - The article highlights that users may face access issues if they have an ad-blocker enabled, suggesting the need to disable it for uninterrupted service [1]

Group 1 - The article does not provide any specific content related to a company or industry [1]

With Verizon leading the pack, these are the 10 biggest telecommunications companies by 12-month trailing revenue. https://t.co/7XV6OXrmcK ...

Then came scale:⚡ 2023 - Reached 8-digit annual revenue⚡ 2024 - Delivered 8-digit profit⚡ 2025 - Surpassed 200M+ global usersThrough bull runs, bear markets, and everything between, Trust Wallet kept growing, with security, freedom, and accessibility at the core. ...

four token trading at 1/4 of https://t.co/31ZmEI0BSv valuation despite generating $1.47m daily revenue vs pump's lower efficiency. binance holds 92% of four supply. that's not exit liquidity that's strategic positioning. fourmeme already proved revenue superiority before meme rush launched. market pricing in competition that might be collaboration. ...

Group 1 - The article does not provide any specific content related to a company or industry [1]